13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-08-14 Event 2026-08-14 SEC 0001213900-26-090085 →

Chen Yi-Kuei → Apollomics Inc. APLMW

Stake: 4.97% Shares: 145,171 CUSIP: G0411D123 Class: Class A ordinary shares, par value $0.01 per share

Item 4 — Purpose of Transaction

Item 4 of the Schedule 13D is hereby amended and supplemented as follows: The information set forth in Item 3 of this Amendment No. 1 is incorporated herein by reference. The Class A Shares acquired by Maxpro in the Private Placement are held for investment purposes. The Reporting Person may, from time to time, review his investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations, prospects, general economic and market conditions, the market price of the Class A Shares, other investment opportunities available to the Reporting Person, and other factors that the Reporting Person may deem relevant. Subject to applicable law, the Reporting Person may acquire additional securities of the Issuer or dispose of some or all of the securities of the Issuer beneficially owned by him, in open market transactions, privately negotiated transactions, or otherwise. Except as may occur in the ordinary course in the Reporting Person's capacity as an officer and director of the Issuer, the Reporting Person does not currently have any plans or proposals that relate to or would result in any of the actions or transactions described in clauses (a) through (j) of Item 4 of Schedule 13D.

Cross-References

Insider Activity (last 365d)
8 transactions
3 buys · 0 sales · 4 awards/exercises
Issuer Cluster
6 13D/G filings on this issuer
5 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-09-30
DTC 3.42
38,378 shares short · -14.3% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-09-15 LIN PETER KUAN-HOW officer Option exercise 10,000 — —
2026-09-15 LIN PETER KUAN-HOW officer F 3,416 $24.02 $82K
2026-09-15 LIN PETER KUAN-HOW officer Option exercise 10,000 — —
2026-09-15 Yen Hung Hsien director Option exercise 500 — —
2026-09-15 Yen Hung Hsien director Option exercise 500 — —
2026-09-14 LIN PETER KUAN-HOW officer Award 6,000 $23.18 $139K
2026-09-14 Yen Hung Hsien director Award 2,000 $23.18 $46K
2026-08-14 Chen Yi-Kuei director, officer Buy 20,000 $15.00 $300K

Other 13D/G Filings on Apollomics Inc.

FiledFormFilerStakeShares
2026-08-17 SCHEDULE 13D/A Chen Hung-Wen 49.76% 1,453,029 view →
2026-04-08 SCHEDULE 13D Chen Yi-Kuei 5.30% 115,071 view →
2026-04-06 SCHEDULE 13D/A Chen Hung-Wen 41.80% 901,362 view →
2023-11-01 SC ORBIMED ADVISORS LLC — — view →
2023-10-02 SC ORBIMED ADVISORS LLC — — view →

Other Filings by Chen Yi-Kuei

FiledFormIssuerStakeShares
2026-04-08 SCHEDULE 13D Apollomics Inc. APLMW 5.30% 115,071 view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →